Examination of Effective Buccal Absorption of Salmon Calcitonin Using Cell-Penetrating Peptide-Conjugated Liposomal Drug Delivery System

References

• Copp DH, Cameron EC. Demonstration of a hypocalcemic factor (calcitonin) in commercial parathyroid extract. Science. 1961;134(3495):2038. doi:10.1126/science.134.3495.2038.a
   PubMedGoogle Scholar
• Chesnut CH 3rd, Azria M, Silverman S, et al. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int. 2008;19(4):479–491. doi:10.1007/s00198-007-0490-1
   PubMed Web of Science ®Google Scholar
• Chesnut CH 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF study group. Am J Med. 2000;109(4):267–276. doi:10.1016/S0002-9343(00)00490-3
   PubMed Web of Science ®Google Scholar
• Calis S, Jeyanthi R, Tsai T, et al. Adsorption of salmon calcitonin to PLGA microspheres. Pharm Res. 1995;12(7):1072–1076. doi:10.1023/A:1016278902839
   PubMed Web of Science ®Google Scholar
• Guggi D, Kast CE, Bernkop-Schnürch A. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Pharm Res. 2003;20(12):1989–1994. doi:10.1023/B:PHAM.0000008047.82334.7d
   PubMed Web of Science ®Google Scholar
• Lee HE, Lee MJ, Park CR, et al. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. J Control Release. 2010;143(2):251–257. doi:10.1016/j.jconrel.2009.12.011
   PubMed Web of Science ®Google Scholar
• Junginger HE, Hoogstraate JA, Verhoef JC. Recent advances in buccal drug delivery and absorption–in vitro and in vivo studies. J Control Release. 1999;62(1–2):149–159. doi:10.1016/S0168-3659(99)00032-2
   PubMed Web of Science ®Google Scholar
• Veuillez F, Kalia YN, Jacques Y, et al. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm. 2001;51(2):93–109. doi:10.1016/S0939-6411(00)00144-2
   PubMed Web of Science ®Google Scholar
• Caon T, Jin L, Simões CMO, et al. Enhancing the buccal mucosal delivery of peptide and protein therapeutics. Pharm Res. 2015;32(1):1–21. doi:10.1007/s11095-014-1485-1
   PubMed Web of Science ®Google Scholar
• Senel S, Kremer M, Katalin N, et al. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotechnol. 2001;2(2):175–186. doi:10.2174/1389201013378734
   PubMedGoogle Scholar
• Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666–1691. doi:10.1016/j.addr.2005.07.003
   PubMed Web of Science ®Google Scholar
• Okafor NI, Nkanga CI, Walker RB, et al. Encapsulation and physicochemical evaluation of efavirenz in liposomes. J Pharm Investig. 2020;50(2):201–208. doi:10.1007/s40005-019-00458-8
   Web of Science ®Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8(1):102. doi:10.1186/1556-276X-8-102
   PubMed Web of Science ®Google Scholar
• Kiio TM, Park S. Physical properties of nanoparticles do matter. J Pharm Investig. 2021;51(1):35–51. doi:10.1007/s40005-020-00504-w
   Web of Science ®Google Scholar
• Zeb A, Cha J-H, Noh AR, et al. Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model. J Pharm Investig. 2020;50(4):373–381. doi:10.1007/s40005-019-00462-y
   Web of Science ®Google Scholar
• Abd El Azim H, Nafee N, Ramadan A, et al. Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int J Pharm. 2015;488(1–2):78–85. doi:10.1016/j.ijpharm.2015.04.052
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160. doi:10.1038/nrd1632
   PubMed Web of Science ®Google Scholar
• Yang TZ, Wang X-T, Yan X-Y, et al. Phospholipid deformable vesicles for buccal delivery of insulin. Chem Pharm Bull. 2002;50(6):749–753. doi:10.1248/cpb.50.749
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006;308(1–2):140–148. doi:10.1016/j.ijpharm.2005.11.006
   PubMed Web of Science ®Google Scholar
• Lankalapalli S, Tenneti VS. Formulation and evaluation of rifampicin liposomes for buccal drug delivery. Curr Drug Deliv. 2016;13(7):1084–1099. doi:10.2174/1567201813666151221145617
   PubMed Web of Science ®Google Scholar
• Bashyal S, Seo J-E, Keum T, et al. Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes. Int J Nanomed. 2018;13:5173–5186. doi:10.2147/IJN.S168310
   PubMed Web of Science ®Google Scholar
• Bashyal S, Seo J-E, Keum T, et al. Development, characterization, and ex vivo assessment of elastic liposomes for enhancing the buccal delivery of insulin. Pharmaceutics. 2021;13(4):565. doi:10.3390/pharmaceutics13040565
   PubMed Web of Science ®Google Scholar
• Kurrikoff K, Gestin M, Langel Ü. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert Opin Drug Deliv. 2016;13(3):373–387. doi:10.1517/17425247.2016.1125879
   PubMed Web of Science ®Google Scholar
• Langel Ü. Handbook of Cell-Penetrating Peptides. CRC press; 2006.
   Google Scholar
• Kim CH, Lee SG, Kang MJ, et al. Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting. J Pharm Investig. 2017;47(3):203–227. doi:10.1007/s40005-017-0329-5
   Google Scholar
• Wang F, Wang Y, Zhang X, et al. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J Control Release. 2014;174:126–136. doi:10.1016/j.jconrel.2013.11.020
   PubMed Web of Science ®Google Scholar
• Gao H, Zhang Q, Yu Z, et al. Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery. Curr Pharm Biotechnol. 2014;15(3):210–219. doi:10.2174/1389201015666140617092552
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang X, Wang N, et al. Cell-penetrating peptide enhanced insulin buccal absorption. Int J Pharm. 2020;584:119469. doi:10.1016/j.ijpharm.2020.119469
   PubMed Web of Science ®Google Scholar
• Keum T, Noh G, Seo J-E, et al. In vitro and ex vivo evaluation of penetratin as a non-invasive permeation enhancer in the penetration of salmon calcitonin through TR146 buccal cells and porcine buccal tissues. Pharmaceuticals. 2020;13(11):408. doi:10.3390/ph13110408
   Web of Science ®Google Scholar
• Kwon SS, Kim SY, Kong BJ, et al. Cell penetrating peptide conjugated liposomes as transdermal delivery system of Polygonum aviculare L. extract. Int J Pharm. 2015;483(1–2):26–37. doi:10.1016/j.ijpharm.2015.01.030
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang Y, Xie X, et al. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials. 2014;35(14):4368–4381. doi:10.1016/j.biomaterials.2014.01.076
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Verhoef JC, Ponec M, et al. TR146 cells grown on filters as a model of human buccal epithelium: permeability of fluorescein isothiocyanate-labelled dextrans in the presence of sodium glycocholate. J Control Release. 1999;60(2–3):223–233. doi:10.1016/S0168-3659(99)00081-4
   PubMed Web of Science ®Google Scholar
• Oh DH, Chun K-H, Jeon S-O, et al. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur J Pharm Biopharm. 2011;79(2):357–363. doi:10.1016/j.ejpb.2011.05.010
   PubMed Web of Science ®Google Scholar
• Dietz GP, Bähr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci. 2004;27(2):85–131. doi:10.1016/j.mcn.2004.03.005
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang L, Fu H, et al. A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes. Acta Pharm Sin B. 2014;4(1):67–73. doi:10.1016/j.apsb.2013.12.004
   PubMed Web of Science ®Google Scholar
• Chen M, Liu X, Fahr A. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application. Int J Pharm. 2011;408(1–2):223–234. doi:10.1016/j.ijpharm.2011.02.006
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Jessop TC, Lewis RS, et al. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc. 2004;126(31):9506–9507. doi:10.1021/ja0482536
   PubMed Web of Science ®Google Scholar
• Walrant A, Bauzá A, Girardet C, et al. Ionpair-π interactions favor cell penetration of arginine/tryptophan-rich cell-penetrating peptides. Biochim Biophys Acta Biomembr. 2020;1862(2):183098. doi:10.1016/j.bbamem.2019.183098
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Jessop TC, Wender PA. Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev. 2005;57(4):495–504. doi:10.1016/j.addr.2004.10.003
   PubMed Web of Science ®Google Scholar
• Sakai N, Matile S. Anion-mediated transfer of polyarginine across liquid and bilayer membranes. J Am Chem Soc. 2003;125(47):14348–14356. doi:10.1021/ja037601l
   PubMed Web of Science ®Google Scholar
• Berlose JP, Convert O, Derossi D, et al. Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem. 1996;242(2):372–386. doi:10.1111/j.1432-1033.1996.0372r.x
   PubMedGoogle Scholar
• Srinivasan B, Kolli AR, Esch MB, et al. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20(2):107–126. doi:10.1177/2211068214561025
   PubMedGoogle Scholar